Skip to main content
Industry News
Blood test shows promise in Alzheimer's detection

Researchers found that the Multimer Detection System-Oligomeric amyloid-beta blood test, which measures amyloid-beta oligomerization, yielded 100% sensitivity and 92% specificity in identifying people at risk for developing Alzheimer's disease. The findings in the Journal of Alzheimer's Disease suggest that amyloid-beta oligomerization "is expected to be of great help in treating dementia," said researcher Youn Young-chul.

Full Story: